The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate

Blood

Volumn 111, Issue 9, 2008, Pages 4532-4541

  Schüler, Andrea ^a   Schwieger, Maike ^a   Engelmann, Afra ^a   Weber, Kristoffer ^a   Horn, Stefan ^a   Müller, Ursula ^a   Arnold, Michael A ^b   Olson, Eric N ^b   Stocking, Carol ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MADS DOMAIN PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR MEF2C; UNCLASSIFIED DRUG; MEF2C PROTEIN, MOUSE; MYOGENIC FACTOR; PROTEIN C JUN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FATE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GRANULOPOIESIS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CYTOLOGY; GRANULOCYTE; HEMATOPOIESIS; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; GRANULOCYTES; HEMATOPOIESIS; MICE; MICE, MUTANT STRAINS; MONOCYTES; MYELOID CELLS; MYOGENIC REGULATORY FACTORS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTORS;

EID: 47149093377     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-10-116343     Document Type: Article

References (75)

1. Rosenbauer F, Koschmieder S, Steidl U, Tenen DG. Effect of transcription-factor concentrations on leukemic stem cells. Blood. 2005;106:1519-1524.
2. Tenen D. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003;3:89-101.
3. Yuki Y. Imotol. Imaizumi M. et al. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci. 2004;95:503-507.
4. Prima V, Gore L, Caires A, et al. Cloning and functional charcterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19){q23;p13.1) in acute lymphoblastic leukemia. Leukemia. 2005;19:806-813.
5. Prima V, Hunger S. Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia. Leukemia. 2007;21:2470-2475.
6. Krivtsov A, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006;441:818-822.
7. Sorensen PH, Chen CS, Smith FO, et al. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest. 1994;93:429-437.
8. Du Y, Spence SE, Jenkins NA, Copeland NG. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood. 2005;106:2498-2505.
9. Black B, Olson E. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol. 1998;14:167-196.
10. McKinsey T Zhang C, Olson E. MEF2: a calciumdependent regulator of cell division, differentiation and death. Trends Biochem Sci. 2002;27:40-47.
11. Verzi M, Agarwal P, Brown C, McCulley D, Schwarz J, Black B. The transcription factor MEF2C is required for craniofacial development. Dev Cell. 2007;12:645-652.
12. Arnold M, Kim Y, Czubryt M, et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell. 2007;12:377-389.
13. Heidenreich K, Linseman D. Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival. Mol Neurobiol. 2004;29:155-165.
14. Flavell S, Cowan C. Kim T et al. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science. 2006;311:1008-1012.
15. Youn H. Chatila T. Liu J. Integration of calcineruin and MEF2 signal by the coactivator p300 during T-cell apoptosis. EMBO J. 2000;19:4323-4331.
16. Savignac M. Mellström B, Naranjo J. Calciumdependent transcription of cytokine genes in T lymphocytes. Eur J Physiol. 2007;454:523-533.
17. Lin Q. Schwarz J. Bucana C, Olson E. Control of mouse cardiac morphogenesis, myogenesis by transcription factor MEF2C. Science. 1997;276:1404-1407.
18. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995;269:1427-1429.
19. Schwieger M, Lohler J, Fischer M, Herwig U, Tenen D, Stocking C. A dominant-negative mutant of C/EBPa, associated with acute myeloid leukernias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse. Blood. 2004;103:2744-2752.
20. Schwieger M, Lohler J, Friel J, Scheller M, Horak I, Stocking C. AMLI-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J Exp Med. 2002;196:1227-1240.
21. Weber K. Bartsch U, Stocking C, Fehse B. A multi-color panel of novel lentiviral "gene ontology' (LeGO) vectors for functional gene analysis. Mol Therapy. 2008; 16:698-706.
22. Beyer W, Westphal M, Ostertag W, von Laer D. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol. 2002;76:1488-1495.
23. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72:8463-8471.
24. Akashi K, Traver D, Miyamoto T, Weissman I. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193-197.
25. Lavau C. Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 1997;16:4226-4237.
26. Dexter T Garland J, Scott D, Scolnick E, Metcalf D. Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med. 1980:152:1036-1047.
27. Meyer J, Jucker M, Ostertag W, Stocking C. Carboxyl-truncated STAT5beta is generated by a nucleus-associated serine protease in early hematopoietic progenitors. Blood. 1998;91:1901-1908.
28. Holtschke T Löhler J. Kanno Y. et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 1996;87:307-317.
29. Scheller M, Foerster J, Heyworth C, et al. Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood. 1999;94:3764-3771.
30. Kato Y, Kravchenko VV, Tapping Rl, Han J, Ulevitch RJ, Lee J-D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 1997;16:7054-7066.
31. Han J, Jiang Y, Li Z, Kravchenko V, Ulevitch R. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature. 1997;386:296-299.
32. Akira S, Takeda K, Kaisho T. Toll-like receptor: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675-680.
33. Friedman A. Transcriptional regulation of granulocyte and monocyte development. Oncogene. 2002;21:3377-3390.
34. Sieweke M, Graf T Atranscription factor party during blood cell differentiation. Curr Opin Genet Dev. 1998;8:545-551.
35. Orkin S. Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet. 2000;1:57-64.
36. Laslo P, Spooner C, Warmflash A, et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell. 2006;126:755-766.
37. Kondo M, Scherer DC, Miyamoto T, et al. Cellfate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 2000;407:383-386.
38. Iwasaki-Arai J, Iwasaki H. Miyamoto T, Watanabe S, Akashi K. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J Exp Med. 2003;197:1311-1322.
39. Radomska H, Bassères D, Zheng R, et al. Block of G/EBP function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med. 2006;203:371-381.
40. Just U, Stocking C, Spooncer E, Dexter T, Ostertag W. Expression of the GM-CSF gene after retroviral transfer in hematopoietic stem cell lines induces synchronous granulocyte-macrophage differentiation. Cell. 1991;64:1163-1173.
41. Tamura T, Nagamura-lnoue T Shmeltzer Z, Kuswata T Ozato K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity. 2000;13:155-165.
42. Rosenbauer F, Kallies A, Scheller M, et al. Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion. EMBO J. 2002;21:211-220.
43. Kallies A, Rosenbauer F, Scheller M, Knobeloch K, Horak I. Accumulation of c-Cbl and rapid termination of colony-stimulating factor 1 receptor signaling in interferon consensus sequence binding protein-deficient bone marrowderived macrophages. Blood. 2002;99:3213-3219.
44. Muzzey D, van Oudenaarden A. When it comes to decisions, myeloid progenitors crave positive feeback. Cell. 2006;126:650-652.
45. Iwasaki H, Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity. 2007; 26:726-740.
46. Nerlov C, Graf T. PU. 1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998;12:2403-2412.
47. Zhang P, Behre G. Pan J, et al. Negative crosstalk between hematopoietic regulators: GATA proteins repress PU. I. Proc Natl Acad Sci U S A. 1999;96:8705-8710.
48. Rekhtman N, Radparvar F Evans T. Skoultchi Al. Direct interaction of hematopoietic transcription factors PU. 1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 1999;13:1398-1411.
49. Reddy VA, Iwarna A, lotzova G, et al. Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU. 1: possible role in lineage commitment decisions. Blood. 2002; 100:483-490.
50. Dahl R, Walsh JC, Lancki D, et al. Regulation of macrophage and neutrophil cell fates by the PU. 1:C/EBPalpha ratio and granulocyte colonystimulating factor. Nat Immunol. 2003;4:1029-1036.
51. Liu H, Keefer J, Wang Q, Friedman A. Reciprocal effects of C/EBPalpha and PKCdelta on JunB expression and monocytic differentiation depend upon the G/EBPalpha basic region. Blood. 2003; 101:3885-3892.
52. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. PU. 1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med. 2005;201:1487-1502.
53. Petrovick M, Hiebert S, Friedman A, Hetherington C, Tenen D, Zhang D. Multiple functional domains of AMLI: PU. 1 and C/EBPa cooperate with different regions of AMLI. Mol Cell Biol. 1998;18:3915-3925.
54. Oelgeschläger M, Nuchprayoon I, Lüscher B, Friedman A. C/EBP, c-Myb, and PU. 1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol. 1996;16:4717-4725.
55. Wang D, D'Costa J, Civin C, Friedman A. C/EBPalpha directs monocytic commitment of primary myeloid progenitors. Blood. 2006;108:1223-1229.
56. Fukuchi Y, Shibata F, Ito M, et al. Comprenhensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBP alpha. EMBO J. 2006;25:3398-3410.
57. Laiosa C, Stadtfeld M, Xie H, de Andres-Aguayo L, Graf T Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU. 1 transcription factors. Immunity. 2006;25:731-744.
58. Xie H, Ye M, Feng R, Graf T Stepwise reprogramming of B cells into macrophages. Cell. 2004;117:663-676.
59. Krishnaraju K, Nguyen H, Liebermann D, Hoffman B. The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells. Mol Cell Biol. 1995;15:5499-5507.
60. Stirewalt D, Radich J. The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer. 2003;3:650-665.
61. Geijsen N, Koenderman L Goffer P. Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. Cytokine Growth Factor Rev. 2001;12:19-25.
62. Wei X, Sun S. Fan R, et al. MEF2C regulates c-Jun but not TNF-a gene expression in stimulated mast cells. Eur J Immunol. 2003;33:2903-2909.
63. Yang S, Galanis A, Sharrocks A. Targeting of p38 mitogeni-activated protein kinases to MEF2 transcription factors. Mol Cell Biol. 1999:19:4028-4038.
64. Gaynor R, Simon K. Koeffler P. Expression of cjun during macrophage differentiation of HL-60 cells. Blood. 1991;77:2618-2623.
65. Lord K, Abdollahi A. Hoffman-Liebermann B, Liebermann D. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol Cell Biol. 1993; 13:841-851.
66. Behre G, Whitmarsh AJ, Coghlan MP, etal.c-Jun is a JNK-independent coactivator of the PU. 1 transcription factor. J Biol Chem. 1999;274:4939-4946.
67. Li AC, Guidez FRB, Collier JG, Glass CK. The macrosialin promoter directs high levels of transcriptional activity in macrophages dependent on combinatorial interactions between PU. 1 and c-Jun. J Biol Chem. 1998;273:5389-5399.
68. Grondin B, Lefrancois M, Tremblay M. et al. c-Jun homodimers can function as a context-specific coactivator. Mol Cell Biol. 2007;27:2919-2933.
69. Steidl LL Rosenbauer F, Verhaak RG, et al. Essential role of Jun family transcription factors in PU. 1 knockdown-induced leukemic stem cells. Nat Genet. 2006;38:1269-1277.
70. Hsu W, Kerppola T, Chen P-L, Curran T, Chen-Kiang S. Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol Cell Biol. 1994;14:268-276.
71. Rangatia J, Vangala R, Treiber N, et al. Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment. Mol Cell Biol. 2002:22:8681-8694.
72. Elagib K, Xiao M, Hussaini I, et al. Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2. Mol Cell Biol. 2004;24:7779-7794.
73. Eferl R, Sibilia M, Hilberg F, et al. Functions of c-Jun in liver and heart development. J Cell Biol. 1999;145:1049-1061.
74. Iwasaki H, Somoza C, Shigematsu H, et al. Distinctive and indispensable roles of PU. 1 in maintenance of hematopoietic stem cells and their differentiation. Blood. 2005;106:1590-1600.
75. Zhang P. Iwasaki-Arai J, Iwasaki H, et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity. 2004;21:853-863.